[144] Xylem Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing: A stockholder filed notice to sell up to 10,421 shares of common stock, with an aggregate market value of $1,590,557.23. The planned sales may occur on the NYSE around 10/30/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services.

The shares were acquired via restricted stock vesting under a registered plan on 02/21/2019 (1,401 shares), 02/27/2023 (3,792), 03/01/2023 (1,185), and 03/01/2024 (4,043), totaling 10,421 shares. Shares outstanding were 243,469,063; this is a baseline figure, not the amount being offered.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10421	1590557.23	243469063	10/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2023	Restricted stock vesting under a registered plan	Issuer			1185	10/30/2025	Not Applicable
Common	03/01/2024	Restricted stock vesting under a registered plan	Issuer			4043	10/30/2025	Not Applicable
Common	02/27/2023	Restricted stock vesting under a registered plan	Issuer			3792	10/30/2025	Not Applicable
Common	02/21/2019	Restricted stock vesting under a registered plan	Issuer			1401	10/30/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many XYL shares are proposed for sale under this Form 144?

The notice covers up to 10,421 shares of common stock.

What is the aggregate market value of the XYL shares to be sold?

The filing lists an aggregate market value of $1,590,557.23.

Which broker is named for the proposed XYL share sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services.

What is the approximate date of sale for the XYL shares?

The filing states an approximate sale date of 10/30/2025.

On which exchange may the XYL shares be sold?

The filing names the NYSE.

How were the XYL shares acquired by the seller?

All shares were acquired via restricted stock vesting under a registered plan on specified dates.

How many XYL shares were outstanding as context?

The filing lists 243,469,063 shares outstanding.